Immunotherapy using CAR T cells shows promising long-term outcomes for people with the blood cancer myeloma
CAR T cell therapy demonstrates significant long-term success in treating myeloma, with a third of patients showing no detectable cancer after five years.
New therapeutic strategies are emerging in cancer treatment, building on immunotherapy successes with promising new methods for safer, targeted tumor delivery.